Concepedia

Author

Ann V. LeFever

Medical College of Wisconsin

Also Known As

A LeFever, A V LeFever, A V Lefever, A. LEFEVER, A. LeFever, A. Lefever, A. V. LEFEVER, A. V. Lefever, A.V. LeFever, ANN V. LEFEVER

46

Publications

840

Citations

14

H-Index

31

Concepts

All Affiliations

Medical College of WisconsinAurora St. Luke's Medical CenterRoger Williams Medical CenterChildren's Hospital of WisconsinChildren's Cancer Center
AV

About

Ann V. LeFever is an author at Medical College of Wisconsin specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

147

2

Cell Biology

4

4

86

3

Cellular Therapies

2

2

24

4

Health Sciences

1

1

11

5

Allergy

1

1

20

Ann V. LeFever

×

17

Publications

776

Citations

14

H-Index

YearCitations

A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants

James M. Mathew, Jessica Voss, Ann V. LeFever,

Scientific Reports

2018

215

Use of Anti-CD3 × Anti-HER2/neu Bispecific Antibody for Redirecting Cytotoxicity of Activated T Cells Toward HER2/neu <sup>+</sup> Tumors

Manjula Sen, D. M. Wankowski, Nina Garlie,

Journal of Hematotherapy & Stem Cell Research

2001

95

Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia <i>in vitro</i> and correlation with graft-<i>vs</i>-leukemia activity <i>in vivo</i>.

R L Truitt, C-Y Shih, Ann V. LeFever,

The Journal of Immunology

1983

81

T Cells Coactivated with Immobilized Anti-CD3 and Anti-CD28 as Potential Immunotherapy for Cancer

Nina Garlie, Ann V. LeFever, Ruth E. Siebenlist,

Journal of Immunotherapy

1999

73

MANIPULATION OF GRAFT-VERSUS-HOST DISEASE FOR A GRAFT-VERSUS-LEUKEMIA EFFECT AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION IN AKR MICE WITH SPONTANEOUS LEUKEMIA/LYMPHOMA1

Robert L. Truitt, Charles C.-Y. Shih, Ann V. LeFever

Transplantation

1986

45

Immune Modulation in Cancer Patients After Adoptive Transfer of Anti-CD3/Anti-CD28–Costimulated T Cells—Phase I Clinical Trial

Lawrence G. Lum, Ann V. LeFever, Jonathan Treisman,

Journal of Immunotherapy

2001

41

Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.

Ann V. LeFever, Akira Funahashi

PubMed

1991

31

Comparison of the TCR ζ-chain with the FcR γ-chain in chimeric TCR constructs for T cell activation and apoptosis

Lifen Ren‐Heidenreich, Ryan Mordini, Thomas J. Hayman,

Cancer Immunology Immunotherapy

2002

31

Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF.

C Rosenfeld, Brian J. Bolwell, Ann V. LeFever,

PubMed

1996

31

Elevated Prostaglandin E2 Levels in Bronchoalveolar Lavage Fluid of Patients with Bronchogenic Carcinoma

Ann V. LeFever, Akira Funahashi

CHEST Journal

1990

30

Page 1